Hepatitis Drugs Market Report

China Hepatitis Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Oct 03, 2023
  • PAGES：178
  • REPORT CODE：GMM1821030
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Hepatitis is an inflammatory condition that occurs due to infection by hepatitis virus. It predominantly affects the liver and also causes damage to other body parts such as digestive system and brain. Apart from viral infections, hepatitis can also be caused by toxic substances, alcohol consumption, and autoimmune diseases. The viruses that cause hepatitis are of several types: A, B, C, D, E, and G. The most common type of hepatitis viruses are A, B, and C. Hepatitis viruses can cause either acute or chronic infections.

    This report elaborates on the current development of the Hepatitis Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Abbvie

    • Vertex Pharmaceuticals

    • Merck

    • Achillion Pharmaceuticals

    • Bristol-Myers Squibb

    • Gilead Sciences

    • GlaxoSmithKline

    • Novartis

    By Type:

    • OLYSIO

    • VIREAD

    • HEPSERA

    • VICTRELIS

    • TYZEKA

    • BARACLUDE

    • SOVALDI

    • EPCLUSA

    • INCIVEK

    • VEMLIDY

    By Application:

    • Hepatitis A

    • Hepatitis E

    • Hepatitis B

    • Hepatitis D

    • Hepatitis C

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Hepatitis Drugs Market Overview 2018-2029

    • 1.1 China Hepatitis Drugs Industry Development Overview

    • 1.2 China Hepatitis Drugs Industry Development History

    • 1.3 China Hepatitis Drugs Industry Market Size (2018-2029)

    • 1.4 China Hepatitis Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Hepatitis Drugs Production Volume, Production Value and Growth Rate of OLYSIO (2018-2029)

      • 1.4.2 China Hepatitis Drugs Production Volume, Production Value and Growth Rate of VIREAD (2018-2029)

      • 1.4.3 China Hepatitis Drugs Production Volume, Production Value and Growth Rate of HEPSERA (2018-2029)

      • 1.4.4 China Hepatitis Drugs Production Volume, Production Value and Growth Rate of VICTRELIS (2018-2029)

      • 1.4.5 China Hepatitis Drugs Production Volume, Production Value and Growth Rate of TYZEKA (2018-2029)

      • 1.4.6 China Hepatitis Drugs Production Volume, Production Value and Growth Rate of BARACLUDE (2018-2029)

      • 1.4.7 China Hepatitis Drugs Production Volume, Production Value and Growth Rate of SOVALDI (2018-2029)

      • 1.4.8 China Hepatitis Drugs Production Volume, Production Value and Growth Rate of EPCLUSA (2018-2029)

      • 1.4.9 China Hepatitis Drugs Production Volume, Production Value and Growth Rate of INCIVEK (2018-2029)

      • 1.4.10 China Hepatitis Drugs Production Volume, Production Value and Growth Rate of VEMLIDY (2018-2029)

    • 1.5 China Hepatitis Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Hepatitis Drugs Sales Volume, Sales Value and Growth Rate of Hepatitis A (2018-2029)

      • 1.5.2 China Hepatitis Drugs Sales Volume, Sales Value and Growth Rate of Hepatitis E (2018-2029)

      • 1.5.3 China Hepatitis Drugs Sales Volume, Sales Value and Growth Rate of Hepatitis B (2018-2029)

      • 1.5.4 China Hepatitis Drugs Sales Volume, Sales Value and Growth Rate of Hepatitis D (2018-2029)

      • 1.5.5 China Hepatitis Drugs Sales Volume, Sales Value and Growth Rate of Hepatitis C (2018-2029)

    • 1.6 China Hepatitis Drugs Market Analysis by Region

      • 1.6.1 North China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Hepatitis Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Hepatitis Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Hepatitis Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Hepatitis Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Hepatitis Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Hepatitis Drugs Industry Development

    Chapter 3 Hepatitis DrugsIndustry Chain Analysis

    • 3.1 Hepatitis Drugs Industry Chain

    • 3.2 Hepatitis Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Hepatitis Drugs Market

    • 3.3 Hepatitis Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Hepatitis Drugs Market

    Chapter 4 China Hepatitis Drugs Market, by Type

    • 4.1 China Hepatitis Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Hepatitis Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Hepatitis Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Hepatitis Drugs Production Volume and Growth Rate of OLYSIO

      • 4.5.2 China Hepatitis Drugs Production Volume and Growth Rate of VIREAD

      • 4.5.3 China Hepatitis Drugs Production Volume and Growth Rate of HEPSERA

      • 4.5.4 China Hepatitis Drugs Production Volume and Growth Rate of VICTRELIS

      • 4.5.5 China Hepatitis Drugs Production Volume and Growth Rate of TYZEKA

      • 4.5.6 China Hepatitis Drugs Production Volume and Growth Rate of BARACLUDE

      • 4.5.7 China Hepatitis Drugs Production Volume and Growth Rate of SOVALDI

      • 4.5.8 China Hepatitis Drugs Production Volume and Growth Rate of EPCLUSA

      • 4.5.9 China Hepatitis Drugs Production Volume and Growth Rate of INCIVEK

      • 4.5.10 China Hepatitis Drugs Production Volume and Growth Rate of VEMLIDY

    Chapter 5 China Hepatitis Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Hepatitis Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Hepatitis Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Hepatitis Drugs Market Size and Growth Rate of Hepatitis A

      • 5.5.2 China Hepatitis Drugs Market Size and Growth Rate of Hepatitis E

      • 5.5.3 China Hepatitis Drugs Market Size and Growth Rate of Hepatitis B

      • 5.5.4 China Hepatitis Drugs Market Size and Growth Rate of Hepatitis D

      • 5.5.5 China Hepatitis Drugs Market Size and Growth Rate of Hepatitis C

    Chapter 6 China Hepatitis Drugs Market, by Region

    • 6.1 China Hepatitis Drugs Production Volume and Production Value, by Region

    • 6.2 China Hepatitis Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Hepatitis Drugs Market Analysis

    • 7.1 North China Hepatitis Drugs Market, by Type

    • 7.2 North China Hepatitis Drugs Market, by Application

    Chapter 8 Central China Hepatitis Drugs Market Analysis

    • 8.1 Central China Hepatitis Drugs Market, by Type

    • 8.2 Central China Hepatitis Drugs Market, by Application

    Chapter 9 South China Hepatitis Drugs Market Analysis

    • 9.1 South China Hepatitis Drugs Market, by Type

    • 9.2 South China Hepatitis Drugs Market, by Application

    Chapter 10 East China Hepatitis Drugs Market Analysis

    • 10.1 East China Hepatitis Drugs Market, by Type

    • 10.2 East China Hepatitis Drugs Market, by Application

    Chapter 11 Northeast China Hepatitis Drugs Market Analysis

    • 11.1 Northeast China Hepatitis Drugs Market, by Type

    • 11.2 Northeast China Hepatitis Drugs Market, by Application

    Chapter 12 Southwest China Hepatitis Drugs Market Analysis

    • 12.1 Southwest China Hepatitis Drugs Market, by Type

    • 12.2 Southwest China Hepatitis Drugs Market, by Application

    Chapter 13 Northwest China Hepatitis Drugs Market Analysis

    • 13.1 Northwest China Hepatitis Drugs Market, by Type

    • 13.2 Northwest China Hepatitis Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Abbvie

        • 14.1.1 Abbvie Company Profile

        • 14.1.2 Abbvie Hepatitis Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Vertex Pharmaceuticals

        • 14.2.1 Vertex Pharmaceuticals Company Profile

        • 14.2.2 Vertex Pharmaceuticals Hepatitis Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Merck

        • 14.3.1 Merck Company Profile

        • 14.3.2 Merck Hepatitis Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Achillion Pharmaceuticals

        • 14.4.1 Achillion Pharmaceuticals Company Profile

        • 14.4.2 Achillion Pharmaceuticals Hepatitis Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Bristol-Myers Squibb

        • 14.5.1 Bristol-Myers Squibb Company Profile

        • 14.5.2 Bristol-Myers Squibb Hepatitis Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Gilead Sciences

        • 14.6.1 Gilead Sciences Company Profile

        • 14.6.2 Gilead Sciences Hepatitis Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 GlaxoSmithKline

        • 14.7.1 GlaxoSmithKline Company Profile

        • 14.7.2 GlaxoSmithKline Hepatitis Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Novartis

        • 14.8.1 Novartis Company Profile

        • 14.8.2 Novartis Hepatitis Drugs Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Hepatitis Drugs Industry Research Conclusions

    • 15.2 Hepatitis Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Hepatitis Drugs Industry Market Size (2018-2029)

    • Figure China Hepatitis Drugs Production Volume, Production Value and Growth Rate of OLYSIO (2018-2029)

    • Figure China Hepatitis Drugs Production Volume, Production Value and Growth Rate of VIREAD (2018-2029)

    • Figure China Hepatitis Drugs Production Volume, Production Value and Growth Rate of HEPSERA (2018-2029)

    • Figure China Hepatitis Drugs Production Volume, Production Value and Growth Rate of VICTRELIS (2018-2029)

    • Figure China Hepatitis Drugs Production Volume, Production Value and Growth Rate of TYZEKA (2018-2029)

    • Figure China Hepatitis Drugs Production Volume, Production Value and Growth Rate of BARACLUDE (2018-2029)

    • Figure China Hepatitis Drugs Production Volume, Production Value and Growth Rate of SOVALDI (2018-2029)

    • Figure China Hepatitis Drugs Production Volume, Production Value and Growth Rate of EPCLUSA (2018-2029)

    • Figure China Hepatitis Drugs Production Volume, Production Value and Growth Rate of INCIVEK (2018-2029)

    • Figure China Hepatitis Drugs Production Volume, Production Value and Growth Rate of VEMLIDY (2018-2029)

    • Figure China Hepatitis Drugs Sales Volume, Sales Value and Growth Rate of Hepatitis A (2018-2029)

    • Figure China Hepatitis Drugs Sales Volume, Sales Value and Growth Rate of Hepatitis E (2018-2029)

    • Figure China Hepatitis Drugs Sales Volume, Sales Value and Growth Rate of Hepatitis B (2018-2029)

    • Figure China Hepatitis Drugs Sales Volume, Sales Value and Growth Rate of Hepatitis D (2018-2029)

    • Figure China Hepatitis Drugs Sales Volume, Sales Value and Growth Rate of Hepatitis C (2018-2029)

    • Figure North China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Hepatitis Drugs Market Size and Growth Rate from 2018-2029

    • Figure Hepatitis Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Hepatitis Drugs Market Share by Type in 2018

    • Figure China Hepatitis Drugs Market Share by Type in 2023

    • Figure China Hepatitis Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Hepatitis Drugs Production Volume and Growth Rate of OLYSIO (2018-2023)

    • Figure China Hepatitis Drugs Production Volume and Growth Rate of VIREAD (2018-2023)

    • Figure China Hepatitis Drugs Production Volume and Growth Rate of HEPSERA (2018-2023)

    • Figure China Hepatitis Drugs Production Volume and Growth Rate of VICTRELIS (2018-2023)

    • Figure China Hepatitis Drugs Production Volume and Growth Rate of TYZEKA (2018-2023)

    • Figure China Hepatitis Drugs Production Volume and Growth Rate of BARACLUDE (2018-2023)

    • Figure China Hepatitis Drugs Production Volume and Growth Rate of SOVALDI (2018-2023)

    • Figure China Hepatitis Drugs Production Volume and Growth Rate of EPCLUSA (2018-2023)

    • Figure China Hepatitis Drugs Production Volume and Growth Rate of INCIVEK (2018-2023)

    • Figure China Hepatitis Drugs Production Volume and Growth Rate of VEMLIDY (2018-2023)

    • Figure China Hepatitis Drugs Market Share by Application in 2018

    • Figure China Hepatitis Drugs Market Share by Application in 2023

    • Figure China Hepatitis Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Hepatitis Drugs Market Size and Growth Rate of Hepatitis A (2018-2023)

    • Figure China Hepatitis Drugs Market Size and Growth Rate of Hepatitis E (2018-2023)

    • Figure China Hepatitis Drugs Market Size and Growth Rate of Hepatitis B (2018-2023)

    • Figure China Hepatitis Drugs Market Size and Growth Rate of Hepatitis D (2018-2023)

    • Figure China Hepatitis Drugs Market Size and Growth Rate of Hepatitis C (2018-2023)

    • Table China Hepatitis Drugs Production Volume by Region (2018-2023)

    • Table China Hepatitis Drugs Production Volume Share by Region (2018-2023)

    • Figure China Hepatitis Drugs Production Volume Share by Region (2018-2023)

    • Table China Hepatitis Drugs Production Value by Region (2018-2023)

    • Table China Hepatitis Drugs Production Value Share by Region (2018-2023)

    • Figure China Hepatitis Drugs Production Value Share by Region (2018-2023)

    • Table China Hepatitis Drugs Sales Volume by Region (2018-2023)

    • Table China Hepatitis Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Hepatitis Drugs Sales Volume Share by Region (2018-2023)

    • Table China Hepatitis Drugs Sales Value by Region (2018-2023)

    • Table China Hepatitis Drugs Sales Value Share by Region (2018-2023)

    • Figure China Hepatitis Drugs Sales Value Share by Region (2018-2023)

    • Table North China Hepatitis Drugs Production Volume by Type (2018-2023)

    • Table North China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Table North China Hepatitis Drugs Sales Volume by Application (2018-2023)

    • Table North China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Hepatitis Drugs Production Volume by Type (2018-2023)

    • Table Central China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Hepatitis Drugs Sales Volume by Application (2018-2023)

    • Table Central China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Hepatitis Drugs Production Volume by Type (2018-2023)

    • Table South China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Table South China Hepatitis Drugs Sales Volume by Application (2018-2023)

    • Table South China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Hepatitis Drugs Production Volume by Type (2018-2023)

    • Table East China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Table East China Hepatitis Drugs Sales Volume by Application (2018-2023)

    • Table East China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Hepatitis Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Hepatitis Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Hepatitis Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Hepatitis Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Hepatitis Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Hepatitis Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Hepatitis Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Hepatitis Drugs Sales Volume Share by Application (2018-2023)

    • Table Abbvie Company Profile

    • Table Abbvie Hepatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Vertex Pharmaceuticals Company Profile

    • Table Vertex Pharmaceuticals Hepatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Hepatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Achillion Pharmaceuticals Company Profile

    • Table Achillion Pharmaceuticals Hepatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Hepatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences Company Profile

    • Table Gilead Sciences Hepatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Hepatitis Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Hepatitis Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US